Pitt–Ohio State HIV Clinical Trials Unit
Pitt-Ohio State Clinical Trials Unit
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11472079
This team runs HIV treatment, prevention, and vaccine studies in Pittsburgh and Columbus to help improve care and protect people at risk.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11472079 on ClinicalTrials.gov |
What this research studies
You would join studies run by the University of Pittsburgh and Ohio State that test new HIV treatments, prevention strategies, and vaccines. Staff screen, enroll, and follow participants over time, collecting medical information and blood or other samples for lab testing. The unit works with national HIV networks (ACTG, HPTN, HVTN) and operates specialty labs to measure viral and immune responses. Participation includes regular clinic visits, safety monitoring, and coordination with study teams to ensure care and data quality.
Who could benefit from this research
Good fit: People living with HIV and individuals at risk for HIV who meet specific study criteria and can attend visits in the Pittsburgh or Columbus areas are ideal candidates.
Not a fit: People who do not meet inclusion criteria, cannot travel to the study sites, or enroll in early-phase protocols may not receive direct medical benefit from participation.
Why it matters
Potential benefit: If successful, this work could speed delivery of better HIV treatments, stronger prevention options, and effective vaccines to people affected by or at risk for HIV.
How similar studies have performed: Prior ACTG, HPTN, and HVTN studies have produced major advances in HIV treatment and prevention, so this unit builds on well-established, successful approaches.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RIDDLER, SHARON — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: RIDDLER, SHARON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.